The contribution of EPC dysfunction to the pathogenesis of HIV-related cardiovascular diseases is an important topic, considering that both the virus and ART can affects this cell population. In this manuscript we highlight the discordance among results of studies addressing this issue and suggest that immunophenotype-definition of endothelail progenitor cells does not reflect accurately the true number of these progenitors.
Teofili, L., Nuzzolo, E. R., Vecchiet, J., Falasca, K., Iachininoto, M. G., Martini, M., Larocca, L. M., Endothelial progenitor cells in HIV-positive patients: what are we talking about?, <<JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES>>, 2013; 62 (1): e22-e22-3. [doi:10.1097/QAI.0b013e3182794745] [http://hdl.handle.net/10807/40536]
Endothelial progenitor cells in HIV-positive patients: what are we talking about?
Teofili, Luciana;Nuzzolo, Eugenia Rosa;Iachininoto, Maria Grazia;Martini, Maurizio;Larocca, Luigi Maria
2013
Abstract
The contribution of EPC dysfunction to the pathogenesis of HIV-related cardiovascular diseases is an important topic, considering that both the virus and ART can affects this cell population. In this manuscript we highlight the discordance among results of studies addressing this issue and suggest that immunophenotype-definition of endothelail progenitor cells does not reflect accurately the true number of these progenitors.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
